(DDM) – Health professionals in Nigeria are raising fresh concerns about snakebite deaths.
Community pharmacists say many of these deaths are preventable.
They are urging the Federal Government to act quickly.
Their appeal is directed at President Bola Ahmed Tinubu’s administration.
They want lifesaving antivenom made free across the country.
Pharmacists argue that cost is a major barrier to treatment.
They say many victims cannot afford urgent care.
The Association of Community Pharmacists of Nigeria has spoken publicly.
The group highlights the scale of the problem.
It describes snakebite envenoming as a neglected health crisis.
Experts say snakebites affect rural and farming communities most.
Many victims are farmers, herders, and children in remote areas.
These groups often live far from equipped hospitals.
Delays in treatment can worsen outcomes.
Quick access to antivenom improves survival chances.
The ACPN estimates thousands die yearly from snakebites.
Its chairman, Pharmacist Ambrose Eze, shared recent figures.
He said about 2,000 Nigerians die annually from complications.
He also noted over 20,000 cases occur each year.
Many survivors face lasting health problems.
Some suffer permanent disabilities.
Limb loss is one serious consequence.
Experts link these outcomes to late treatment.
They also blame weak drug supply systems.
Some hospitals reportedly lack antivenom stocks.
Others must refer patients elsewhere.
Referrals can cost precious time.
Time is critical in snakebite care.
Medical workers stress early intervention.
Antivenom neutralizes venom in the body.
Without it, complications can increase.
Treatment costs are another concern.
Pharmacists say a dose may cost around ₦40,000.
That amount is high for many families.
Out-of-pocket payments remain common in Nigeria.
Health insurance coverage is still limited.
The pharmacists propose a solution.
They want antivenom included under NHIA coverage.
They say this would reduce financial pressure.
It could also increase hospital readiness.
They also recommend local production.
Local manufacturing may lower costs.
It may also improve availability.
Nigeria relies heavily on imported antivenom.
Importation can face delays and shortages.
Global health bodies recognize snakebite as a tropical disease.
The World Health Organization has flagged the issue before.
Snakebites are common in parts of Africa and Asia.
Climate and environment play a role.
Bushy and agricultural zones see higher cases.
Public awareness is another challenge.
Some victims first seek traditional remedies.
Medical experts advise hospital treatment instead.
They say proper care saves more lives.
Pharmacists emphasize that every life matters.
They call for stronger government commitment.
They want funding and policy support.
They believe prevention and access must improve.
Observers say the appeal adds pressure on policymakers.
They note rising focus on public health funding.
Citizens continue to watch government response.
Health advocates hope for quick action.
They say free antivenom could save many lives.
They also say it would support vulnerable communities.
The debate now centers on funding priorities.
For many families, the issue is urgent.
For pharmacists, the message is simple.
They say treatment should not depend on wealth.
They insist lifesaving drugs must be accessible.
They believe nationwide coverage is achievable.
They argue political will is key.
As cases continue yearly, concern remains high.
Health workers say prevention and readiness must go together.
They conclude that early care saves lives.
